Dan is a co-founder and managing partner at OMX Ventures, where he invests in and builds companies across OMX’s sectors of interest. A technologist at heart, Dan gravitates towards platform companies that utilize a strong data approach to product discovery and development.
Within the portfolio, Dan is dedicated to supporting founding teams as they translate scientific discoveries into real-world products efficiently, and he currently works with portfolio companies including Mythic Therapeutics, ReAx Biotechnologies, Matterworks, Type6 Therapeutics and Cellsonics. He is also the co-founder of precision oncology company Uereka Biosciences.
Prior to OMX Ventures Dan was a venture investor with Merieux Equity Partners, and a strategy consultant with L.E.K. Consulting in Boston. Dan earned a PhD in Biomedical Sciences from UCSD, where he tried to figure out how blood vessels form a tube (mostly unsuccessfully), and also holds a BA in biology from Rhode Island College.
Outside of work Dan enjoys spending time with his family, stacking firewood each spring, and teaching unathletic dogs to catch frisbee.
